Researchers correct cystic fibrosis using new CRISPR/Cas9 variant technique

Recently published research [1] provides new hope for a potential cure for the devastating cystic fibrosis disease. In the study, a research collaboration demonstrated how they corrected mutations that cause cystic fibrosis in cultured human stem cells using a CRISPR/Cas9 variant technique called prime editing to replace the ‘faulty’ piece of DNA with a healthy […]

Jürgen Semmler appointed new managing director at Shimadzu Europe

Shimadzu, one of the world leaders in analytical instrumentation, has appointed Jürgen Semmler as the new managing director of its European organization from July 1, 2021. Previously, head of Shimadzu Deutschland, he succeeds Jürgen Kwass, who led Shimadzu Europa from 2003 to the present and is now retiring. Semmler and Kwass have both been affiliated […]

German Cancer Research Centre plans to use quantum computer to personalise cancer treatment

As a partner of the Fraunhofer Competence Network Quantum Computing, the German Cancer Research Center is planning to use the quantu m computer in Ehningen, Baden-Württemberg, to develop individually effective cancer treatment methods.

Medovate expands SAFIRA product range with further CE Mark approvals

Medovate has successfully secured additional CE Mark approvals for its SAFIRA (SAFer Injection for Regional Anaesthesia) technology to include an NRFit syringe and a Palm Operator

Minaris to be commercial manufacturer in Europe for Skysona, bluebird bio’s gene therapy for CALD

Minaris Regenerative Medicine, a leading contract development and manufacturing organization for the cell and gene therapy industry, will be the commercial manufacturer in Europe for bluebird bio’s Skysona (elivaldogene autotemcel, formerly Lenti-D gene therapy), for the treatment of Early Cerebral Adrenoleukodystrophy (CALD).

DeepMind and EMBL release the most complete database of predicted 3D structures of human proteins

DeepMind has partnered with the European Molecular Biology Laboratory (EMBL), Europe’s flagship laboratory for the life sciences, to make the most complete and accurate database yet of predicted protein structure models for the human proteome.

Owen Mumford receives RoSPA gold award for health and safety achievements

Owen Mumford has been awarded a RoSPA (Royal Society for the Prevention of Accidents) gold health and safety award. The awarded is given to organisations that achieve exceptional control of risk with very low levels of error, harm and loss.

TeamViewer, Siemens Healthineers form partnership to enable new remote scanning service WeScan for diagnostic imaging

Siemens Healthineers has recently started offering its customers WeScan. WeScan is a new service that helps healthcare providers to perform magnetic resonance imaging (MRI) examinations if they lack qualified radiology staff. With the WeScan service, customers may seek access to a pool of skilled remote imaging technologists who help operate the MRI scanner using syngo […]

Automation is key to saving lives

Personalized tumour treatments are expensive. This particularly applies to individual cancer therapies based on gene-modified T cells. Currently, they are produced manually or, at best, in a partially automated process. In a collaboration project “ProCell for Patient” two hospitals are currently working with Optima Pharma to develop an automated unit for the decentralized production of […]

Apic Bio receives FDA Fast Track Designation for APB-102 for treatment of patients with SOD1 ALS

The US FDA has granted Fast Track designation to APB-102, Apic Bio’s lead gene therapy candidate designed to treat SOD1 amyotrophic lateral sclerosis (ALS). Apic said they plan to commence a Phase 1/2 clinical trial in early 2022.